Business Trends– category –
-
STMicroelectronics Expands AI Data Center Silicon Photonics Market with PIC100 Chip Order from Chinese Customer
Business Korea South Korea Overview STMicroelectronics is actively expanding its silicon photonics market presence to meet growing AI data center demand. The company secured an order for its PIC100 chips from a major Chinese optical tran... -
Kuramoto Seisakusho Stock Surges Following Investment Framework Agreement with Hong Kong Firm for Perovskite Solar Cell Business
Moomoo (Fisco Japan) Japan Overview Kuramoto Seisakusho announced an investment framework agreement with a Hong Kong company for its perovskite solar cell business, causing its stock price to surge. This agreement signals a crucial strat... -
Roche Diagnostics Strengthens Comprehensive POCT Portfolio, Driving Rapid and Accurate On-Site Diagnostics for Critical Conditions
Roche Diagnostics Switzerland Overview Roche Diagnostics, in an update dated June 23, 2026, announced the strengthening of its comprehensive Point of Care (POCT) solutions portfolio. The company emphasizes the critical role of POCT in fr... -
ASCO Annual Meeting 2026 Signals New Era in Lung Cancer Treatment: Adjuvant Targeted Therapy and ADCs Reshape Immunotherapy Strategies
Targeted Oncology USA Overview Targeted Oncology reports that three key lung cancer abstracts from the ASCO 2026 Annual Meeting could significantly alter clinical practice. These presentations highlight advances in adjuvant targeted ther... -
Anodyne Nanotech Raises $12.6 Million Series A to Advance Once-Weekly GLP-1 Patch ANN-101 into Phase I Clinical Trials
BioSpace USA Overview Anodyne Nanotech Inc., a clinical-stage biotechnology company, has secured $12.6 million in Series A funding to propel its once-weekly GLP-1 patch, ANN-101, for obesity treatment into Phase I clinical trials. The co... -
Nanotechnology-Based Drug Delivery Systems Drive Personalized Medicine with Approved Formulations for Diverse Diseases
IJSRT Journal India Overview Nanotechnology-based Drug Delivery Systems (NDDS) have overcome limitations of conventional therapies by enhancing drug solubility, absorption, stability, and bioavailability, enabling targeted delivery to sp... -
Cytiva Advances In Vivo CAR-T Therapy with Targeted mRNA-LNP Delivery to the Spleen
Cytiva スウェーデン Overview Cytiva is making significant strides in *in vivo* CAR-T therapy by utilizing advanced lipid nanoparticle (LNP) systems for direct T cell reprogramming within patients. This innovative approach extends LNP del... -
Argo Graphene Solutions Closes License Agreement for Grapherry’s STREAM Graphene Production Platform
Newsfile Corp. via StockTitan Canada Overview Argo Graphene Solutions Corp. has finalized a license agreement with Grapherry, Inc. for Grapherry's proprietary STREAM graphene production platform and related intellectual property. Grapher... -
Beam Therapeutics Receives FDA IND Clearance for Liver-Targeted LNP Formulation BEAM-304 for Phenylketonuria (PKU) Treatment
Beam Therapeutics USA Overview Beam Therapeutics announced FDA IND clearance for BEAM-304, a liver-targeting lipid-nanoparticle (LNP) formulation of base editing reagents, for the treatment of Phenylketonuria (PKU). Designed to correct m... -
Samsung Biologics Expands Bio R&D Center Beyond CDMO Support, Investing in Next-Gen Modalities, AI, and Machine Learning
Korea Biomedical Review (KBR) South Korea Overview Samsung Biologics is significantly expanding its Bio R&D Center beyond traditional Contract Development and Manufacturing Organization (CDMO) support. The company is focusing on thre...
